The earnings train steams along. After a week of largely positive quarterly results from leading technology companies, the focus in the coming days turns to leading blue-chip companies, many of which are household names. Over the next week, we will hear from several top tier prescription drug makers, travel companies, technology companies, and food and
0 Comments
In this article BRK.A Warren Buffett on Saturday said Berkshire Hathaway has been increasing its stake in Activision Blizzard in a merger arbitrage play, betting that Microsoft’s proposed acquisition of the video game company will close. Berkshire now owns about 9.5% of Activision shares, Buffett said at the company’s annual shareholder meeting. “Occasionally I’ll see
0 Comments
Technical indicators are used by traders to gain insight into the supply and demand of securities and market psychology. Together, these indicators form the basis of technical analysis. Metrics, such as trading volume, provide clues as to whether a price move will continue. In this way, indicators can be used to generate buy and sell signals. In this
0 Comments
In this article BRK.A Berkshire Hathaway CEO Warren Buffett lambasted Wall Street for encouraging speculative behavior in the stock market, effectively turning it into a “gambling parlor.” Buffett, 91, spoke at length during his annual shareholder meeting Saturday about one of his favorite targets for criticism: investment banks and brokerages. “Wall Street makes money, one
0 Comments
Energy stocks are a great investment to protect your portfolio against rising inflation and equity market dips. Enbridge (ENB): The solid fundamentals and the strong cash flow stream provide support for this leading North American energy stock. Dominion Energy (D): This utility stock has high profit margins and robust growth. Duke Energy (DUK): After improving renewable energy generation
0 Comments
Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG) has been under pressure lately, and earnings didn’t help. GOOGL stock had its fifth straight week, down around 4% in the week ending April 29. However, a dip like this should attract buyers, not scare them away. After going through the earnings report, there are many positives. The company grew revenue 23%
0 Comments
After multiple neurology experts harshly criticized Cassava Sciences’ (NASDAQ:SAVA) main thesis and the integrity of its data, I strongly recommend investors refrain from owning any shares of SAVA stock. In my many years of writing about pharmaceutical companies, I’ve never seen multiple experts criticize a drug maker so harshly. These professionals’ tremendous skepticism towards Cassava
0 Comments
Tracey Ryniec uncovers two top stocks that are flying under the radar. Applied Optoelectronics: https://www.zacks.com/stock/quote/AAOI?cid=CS-YOUTUBE-FT-VID Bio Telemetry: https://www.zacks.com/stock/quote/BEAT?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
0 Comments